Abstract
Objectives
To evaluate therapeutic outcomes of intraluminal brachytherapy (ILBT) for malignant obstructive jaundice (MOJ) against stent alone.
Methods
The PubMed, EMBASE, Cochrane Library, CNKI, Wan Fang, VIP and ClinicalTrials.gov databases were searched for all relevant comparative studies from the earliest available date up to 1 May 2017. Subgroup analyses were performed according to the type of study design and type of stent.
Results
Twelve studies that compared ILBT versus stent alone were eligible. A total of 641 participants with MOJ were included in our meta-analysis. A total of 340 participants were treated with intraluminal brachytherapy (ILBT); the other 301 participants were treated with biliary stent alone (stent group). ILBT was associated with lower risk of stent occlusion (OR 0.19; 95% CI 0.13–0.28; P < 0.00001) and better mean survival (MD = 3.15; 95% CI 2.64–3.66; P < 0.00001) compared with stent alone. However, the two groups were similar in number of complications (OR 0.84; 95% CI 0.45–1.56; P = 0.578), post-treatment reduced level of total bilirubin (TBIL) (MD = 22.71; 95% CI − 7.24–52.65; P = 0.14), post-treatment reduced level of direct bilirubin (DBIL) (MD = − 3.67; 95% CI − 14.09–6.75; P = 0.49), post-treatment reduced level of alanine aminotransferase (ALT) (MD = 21.09; 95% CI − 5.09–47.28; P = 0.11) and post-treatment reduced level of aspartate aminotransferase (AST) (MD = 20.86; 95% CI − 45.86–87.58; P = 0.54).
Conclusions
ILBT was significantly superior to stent alone in terms of stent occlusion and mean survival. Meanwhile, ILBT had comparable outcomes to stent alone in terms of complications and post-treatment reduced levels of TBIL, DBIL, ALT and AST. Therefore, ILBT may be considered a preferable technique for MOJ.
Similar content being viewed by others
References
Bismuth H, Castaing D, Traynor O. Resection or palliation: priority of surgery in the treatment of hilar cancer. World J Surg. 1988;12:39–47.
Stain SC, Baer HU, Dennison AR, Blumgart LH. Current management of Hilar cholangiocarcinoma. Surg Gynecol Obstet. 1992;175:579–88.
Davids PHP, Groen AK, Rauws EAJ, Tytgat GNJ, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet. 1992;340:1488.
Han YH, Kim MY, Kim SY, Kim YH, Hwang YJ, Seo JW, et al. Percutaneous insertion of zilver stent in malignant biliary obstruction. Abdom Radiol. 2006;31:433–8.
Yasumoto T, Yokoyama S, Nagaike K. Percutaneous transcholecystic metallic stent placement for malignant obstruction of the common bile duct: preliminary clinical evaluation. J Vasc Interv Radiol. 2010;21:252–8.
Kim HS, Lee DK, Kim HG, Park JJ, Park SH, Kim JH, et al. Features of malignant biliary obstruction affecting the patency of metallic stents: a multicenter study. Gastrointest Endosc. 2002;55:359–65.
Monk BJ, Tewari KS, Puthawala AA, Syed AM, Haugen JA, Burger RA. Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys. 2002;52:806–15.
Guo JH, Teng GJ, Zhu GY, He SC, Fang W, Deng G, et al. Self-expandable esophageal stent loaded with 125I seeds: initial experience in patients with advanced esophageal cancer. Radiology. 2008;247:574–81.
Hasimu A, Gu JP, Ji WZ, Zhang HX, Zhu DW, Ren WX. Comparative study of percutaneous transhepatic biliary stent placement with or without iodine-125 seeds for treating patients with malignant biliary obstruction. J Vasc Interv Radiol. 2017;28:583–93.
Chen Y, Wang XL, Yan ZP, Wang JH, Cheng JM, Gong GQ, et al. The use of 125I seed strands for intraluminal brachytherapy of malignant obstructive jaundice. Cancer Biother Radiopharm. 2011;27:317–23.
Zhu HD, Guo JH, Zhu GY, He SC, Fang W, Deng G, et al. A novel biliary stent loaded with 125I seeds in patients with malignant biliary obstruction: preliminary results versus a conventional biliary stent. J Hepatol. 2012;56:1104–11.
Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17:1–12.
Bañares R, Albillos A, Rincón D, et al. Endoscopic treatment versus endoscopic plus pharmacologic treatment for acute variceal bleeding: a meta-analysis. Hepatology. 2002;35(3):609–15.
Zhang M, Chen C, Wang X, et al. Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of Heficobacter pylori as the rescue therapy: a meta analysis. Chin J Intern Med. 2017;56(5):368–74.
Wells GA, Shea BJ, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. Appl Eng Agric. 2000;18:727–34.
Qi X, Jia J, Bai M, et al. Transjugular intrahepatic portosystemic shunt for acute variceal bleeding: a meta-analysis. J Clin Gastroenterol. 2014;49(6):495–505.
The Cochrane Collaboration: RevMan 4.2 User Guide 2005. http://www.cc-ims.net/RevMan/documentation.htm. Oxford: The Cochrane Collaboration.
Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719–48.
Dersimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.
Yang Z, Han G, Wu Q, et al. Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene-covered stents versus bare stents: a meta-analysis. J Gastroenterol Hepatol. 2010;25(11):1718–25.
Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–60.
Poulou LS, Thanos L, Ziakas PD. Unifying the predictive value of pretransplant FDG PET in patients with lymphoma: a review and meta-analysis of published trials. Eur J Nucl Med Mol Imaging. 2010;37(1):156–62.
Chevalier TL, Scagliotti G, Natale R, et al. Efficacy of gemcitabine plus platinum chemotherapy compared with other platinum containing regimens in advanced non-small-cell lung cancer: a meta-analysis of survival outcomes. Lung Cancer. 2005;47(1):69–80.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629–34.
Han CL, Ma YL, Ou SQ, Zhao C, Meng ZB. 125I seed-strip combined with biliary stent implantation for malignant obstructive jaundice: clinical analysis of 22 cases. J Interv Radiol. 2015;24:141–5.
Jiang H, Zhao H, Zhao SM, Gu WW, Yang XH, Gu ZX, et al. Clinical efficacy evaluation of biliary stent versus biliary stent combined with 125I-seed bar implantations for the treatment of cholangiocarcinoma with obstructive jaundice. Chin J Clin Res. 2015;28:1425–8.
Pan HT, Liu HC, Fei SX, Li ZK, Wang Y, Yin YL. Clinical efficacy evaluation of biliary stent combined with 125I-seed implantations for the treatment of hilar cholangiocarcinoma with obstructive jaundice. Chin J Radiol. 2016;50:393–6.
Yao HX, Chen GS, Ye GX, Xu SQ, Wu CJ, Qin Y, et al. Biliary stent versus combined biliary stent with intracavitary irradiation using 125I seed implantation in the treatment of malignant obstructive jaundice. Chin J Hepatobiliary Surg. 2014;20:869–72.
Liu MQ, Zhuang SE, Liu LS. Clinical efficacy evaluation of biliary stent combined with 125I-seed implantations for the treatment of malignant obstructive jaundice. Fujian Med J. 2016;38:28–30.
Wang T, Liu S, Zheng YB, Song XP, Jiang WJ, Sun BL, et al. Application of 125I seeds combined with biliary stent implantation in the treatment of malignant obstructive jaundice. Chin J Oncol. 2016;38:228–31.
Chen W, Ni CF, Wang X, Huang JS, Hu CH. Percutaneous 125I seed-loaded stent implantation for the treatment of malignant obstructive jaundice: analysis of clinical efficacy. J Interv Radiol. 2015;24:138–40.
Li WH, Luo JJ, Dai ZY, Yao LZ, Dong CS, Zhu J, et al. Intraluminal brachytherapy combined with stent placement for the treatment of malignant obstructive jaundice. J Interv Radiol. 2015;24:215–8.
Zhang YY, Ma YH, Zhang FX. Clinical effectiveness analysis on biliary stent combined with 125I seed implantation in the treatment of malignant obstructive jaundice. Chin J Curr Adv Gen Surg. 2017;20:100–4.
Reniers B, Verhaegen F, Vynckier S. The radial dose function of low-energy brachytherapy seeds in different solid phantoms: comparison between calculations with the EGSnrc and MCNP4C Monte Carlo codes and measurements. Phys Med Biol. 2004;49(8):1569–82.
Chino K, Silvain D, Grace A, Stubbs J, Stea B. Feasibility and safety of outpatient brachytherapy in 37 patients with brain tumors using the GliaSite Radiation Therapy System. Med Phys. 2008;35:3383–8.
Acknowledgements
Thanks are due to Jingjing Li, Juan Wu and Rui Zhu for assistance with the study and to Wenbin Ji for valuable discussion.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that they have no conflict of interest.
Ethical Approval Statement
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
Informed Consent
None.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Xu, X., Li, J., Wu, J. et al. A Systematic Review and Meta-analysis of Intraluminal Brachytherapy Versus Stent Alone in the Treatment of Malignant Obstructive Jaundice. Cardiovasc Intervent Radiol 41, 206–217 (2018). https://doi.org/10.1007/s00270-017-1827-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-017-1827-6